NCI's Research on COVID-19, Vaccines, and Antibodies - NCI

$ 24.50

4.8
(654)
In stock
Description

What are COVID-19 antibodies, is there a certain level needed for protection, and how well do COVID-19 vaccines work in people with cancer? In this Q&A, NCI experts discuss emerging research findings from the SeroNet program that are shedding light on these and other important questions.

COVID SCIENCE Oxygen level while walking identifies at-risk patients; cancer patients should get vaccine priority

Antibodies and Vaccines as Drugs for COVID-19, keystone symposia

National Cancer Institute (NCI) on LinkedIn: Study Identifies Crucial Characteristic of High-Risk HPV

NCI's Research on COVID-19, Vaccines, and Antibodies - NCI

image0001.jpg

neutralizing antibodies – NIH Director's Blog

New U of A-based study to examine very rare adverse events linked to COVID-19 vaccines

Cancer in the Midst of COVID-19, A Report

T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

No small matter: a perspective on nanotechnology-enabled solutions to fight COVID-19